Kayla Deshong, PA
Physician Assistant · Alameda
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 7
Offices
7 locations · Carbon Health Medical Group of California PC · 335 clinicians in this group
Looking this up.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Kayla Deshong’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$5,673
Medicare paid this office $5,673 for 56 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 18 | $1,861 | $85 |
| New patient visit (45+ min) | 19 | $1,410 | $74 |
Who their Medicare patients are
56 Original Medicare patients in 2024. Average age 74 · Women 57% · Health risk score 0.61. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 63% · Diabetes 29% · Coronary heart disease 21%.
The office billed $32,817, Medicare allowed $9,925 and paid $5,673; for 146 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 56 | 146 | 74 | 0.61 | $32,817 | $5,673 |
| 2023 | 92 | 136 | 73 | 0.94 | $44,898 | $9,042 |
| 2022 | 26 | 53 | 74 | 0.72 | $12,489 | $3,204 |
| 2021 | 77 | 426 | 50 | 1.38 | $98,441 | $46,384 |
| 2020 | 37 | 1,334 | 45 | 1.68 | $121,946 | $60,895 |
| 2019 | 71 | 1,178 | 50 | 1.66 | $172,113 | $72,883 |
| 2018 | 92 | 1,835 | 46 | 1.63 | $235,585 | $94,479 |
| 2017 | 28 | 186 | 45 | 2.09 | $31,599 | $10,064 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| New patient visit (45+ min) | 34 | $3,573 | $105 |
| Return visit (30+ min) | 24 | $2,463 | $95 |
| Short return visit (20+ min) | 12 | $702 | $59 |
2022: 1 service
| New patient visit (30+ min) | 16 | $1,514 | $95 |
2021: 4 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 17 | $12,521 | $199 |
| Return visit (30+ min) | 63 | $11,435 | $85 |
| Long return visit (40+ min) | 23 | $10,263 | $133 |
| Testing for presence of drug, by chemistry analyzers | 28 | $7,270 | $62 |
2020: 3 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 25 | $28,146 | $198 |
| Return visit (30+ min) | 35 | $15,616 | $68 |
| Testing for presence of drug, by chemistry analyzers | 33 | $10,285 | $62 |
2019: 5 services
| Testing for presence of drug, by chemistry analyzers | 64 | $31,453 | $63 |
| Short return visit (20+ min) | 46 | $15,961 | $54 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 18 | $13,050 | $195 |
| Return visit (30+ min) | 25 | $6,731 | $80 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $2,150 | $17 |
2018: 6 services
| Testing for presence of drug, by chemistry analyzers | 92 | $55,045 | $70 |
| Short return visit (20+ min) | 85 | $31,819 | $51 |
| New patient visit (45+ min) | 22 | $2,399 | $109 |
| Urine pregnancy test | 34 | $2,355 | $8 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 28 | $1,904 | $16 |
| Return visit (30+ min) | 12 | $942 | $72 |
2017: 2 services
| Short return visit (20+ min) | 25 | $7,848 | $54 |
| Testing for presence of drug, by chemistry analyzers | 12 | $754 | $63 |
Medicaid work
$69,176 in 2021
Medicaid paid $69,176 for 1,242 billed services this clinician did in 2021, up to 47 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 211 | $23,961 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 457 | $15,891 |
| Long return visit (40+ min) | 259 | $15,587 |
| Return visit (30+ min) | 301 | $12,570 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 14 | $1,166 |
| 2021 | 1,242 | 5 | 47 | $69,176 |
| 2020 | 1,883 | 4 | 47 | $91,115 |
| 2019 | 4,558 | 7 | 94 | $161,091 |
| 2018 | 6,295 | 4 | 90 | $196,943 |
See the largest Medicaid services in earlier years
2020
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 661 | $50,153 |
| Return visit (30+ min) | 454 | $20,951 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 716 | $16,331 |
| Long return visit (40+ min) | 52 | $3,680 |
2019
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 2,048 | $74,615 |
| Short return visit (20+ min) | 1,272 | $51,470 |
| Alcohol and/or substance abuse services, skills development | 64 | $19,440 |
| OFF/OP EST MAY X REQ PHY/QHP | 483 | $5,252 |
| Return visit (30+ min) | 143 | $4,983 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 48 | $2,733 |
| URINE PREGNANCY TEST | 500 | $2,599 |
2018
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 3,045 | $105,431 |
| Short return visit (20+ min) | 2,214 | $84,232 |
| OFF/OP EST MAY X REQ PHY/QHP | 437 | $4,645 |
| URINE PREGNANCY TEST | 599 | $2,635 |
Money from drug and device companies
$19 in 2024
A payment is not proof that care is biased.
| Hologic Sales and Service | Aptima | $19 | 1 payment
|
See the published payment
| Hologic Sales and Service | Meals · 2024-01-25 | Aptima | $19 |
Professional record
- NPI
- 1528514593
- Licence
- MA PA5813
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 1411 Berryessa Rd Ste 30, San Jose, CA, 95133
- NPI first listed
- 2016-08-30
- NPI last updated
- 2024-11-06
- NPI record certified
- 2024-11-06
This is when the NPI record was last certified, not a medical board exam.